117 related articles for article (PubMed ID: 28385250)
21. Novel amphiphilic chitosan nanocarriers for sustained oral delivery of hydrophobic drugs.
Motiei M; Kashanian S
Eur J Pharm Sci; 2017 Mar; 99():285-291. PubMed ID: 28057549
[TBL] [Abstract][Full Text] [Related]
22. In vitro assessment of the interactions of dopamine β-hydroxylase inhibitors with human P-glycoprotein and Breast Cancer Resistance Protein.
Bicker J; Alves G; Fortuna A; Soares-da-Silva P; Falcão A
Eur J Pharm Sci; 2018 May; 117():35-40. PubMed ID: 29428540
[TBL] [Abstract][Full Text] [Related]
23. Inhibition mechanism of P-glycoprotein mediated efflux by mPEG-PLA and influence of PLA chain length on P-glycoprotein inhibition activity.
Li W; Li X; Gao Y; Zhou Y; Ma S; Zhao Y; Li J; Liu Y; Wang X; Yin D
Mol Pharm; 2014 Jan; 11(1):71-80. PubMed ID: 24256068
[TBL] [Abstract][Full Text] [Related]
24. In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein.
Föger F; Hoyer H; Kafedjiiski K; Thaurer M; Bernkop-Schnürch A
Biomaterials; 2006 Dec; 27(34):5855-60. PubMed ID: 16919723
[TBL] [Abstract][Full Text] [Related]
25. Development of a protective dermal drug delivery system for therapeutic DNAzymes.
Marquardt K; Eicher AC; Dobler D; Mäder U; Schmidts T; Renz H; Runkel F
Int J Pharm; 2015 Feb; 479(1):150-8. PubMed ID: 25541146
[TBL] [Abstract][Full Text] [Related]
26. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
[TBL] [Abstract][Full Text] [Related]
27. Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability.
He W; Yang K; Fan L; Lv Y; Jin Z; Zhu S; Qin C; Wang Y; Yin L
Int J Pharm; 2015 Nov; 495(1):9-18. PubMed ID: 26325310
[TBL] [Abstract][Full Text] [Related]
28. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
[TBL] [Abstract][Full Text] [Related]
29. Comparison of poly(ε-caprolactone) chain lengths of poly(ε-caprolactone)-co-d-α-tocopheryl-poly(ethylene glycol) 1000 succinate nanoparticles for enhancement of quercetin delivery to SKBR3 breast cancer cells.
Suksiriworapong J; Phoca K; Ngamsom S; Sripha K; Moongkarndi P; Junyaprasert VB
Eur J Pharm Biopharm; 2016 Apr; 101():15-24. PubMed ID: 26802701
[TBL] [Abstract][Full Text] [Related]
30. Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia.
To KK; Poon DC; Wei Y; Wang F; Lin G; Fu LW
Biochem Pharmacol; 2015 Sep; 97(1):27-37. PubMed ID: 26206183
[TBL] [Abstract][Full Text] [Related]
31. Synergistic effect of quercetin and pH-responsive DEAE-chitosan carriers as drug delivery system for breast cancer treatment.
de Oliveira Pedro R; Goycoolea FM; Pereira S; Schmitt CC; Neumann MG
Int J Biol Macromol; 2018 Jan; 106():579-586. PubMed ID: 28807690
[TBL] [Abstract][Full Text] [Related]
32. The efficiency and mechanism of N-octyl-O, N-carboxymethyl chitosan-based micelles to enhance the oral absorption of silybin.
Yin T; Zhang Y; Liu Y; Chen Q; Fu Y; Liang J; Zhou J; Tang X; Liu J; Huo M
Int J Pharm; 2018 Jan; 536(1):231-240. PubMed ID: 29162374
[TBL] [Abstract][Full Text] [Related]
33. The antiepileptic drug lamotrigine is a substrate of mouse and human breast cancer resistance protein (ABCG2).
Römermann K; Helmer R; Löscher W
Neuropharmacology; 2015 Jun; 93():7-14. PubMed ID: 25645391
[TBL] [Abstract][Full Text] [Related]
34. Curcumin-carboxymethyl chitosan (CNC) conjugate and CNC/LHR mixed polymeric micelles as new approaches to improve the oral absorption of P-gp substrate drugs.
Ni J; Tian F; Dahmani FZ; Yang H; Yue D; He S; Zhou J; Yao J
Drug Deliv; 2016 Nov; 23(9):3424-3435. PubMed ID: 27198856
[TBL] [Abstract][Full Text] [Related]
35. Thiomer-coated liposomes harbor permeation enhancing and efflux pump inhibitory properties.
Gradauer K; Dünnhaupt S; Vonach C; Szöllösi H; Pali-Schöll I; Mangge H; Jensen-Jarolim E; Bernkop-Schnürch A; Prassl R
J Control Release; 2013 Feb; 165(3):207-15. PubMed ID: 23228848
[TBL] [Abstract][Full Text] [Related]
36. Preactivated thiolated pullulan as a versatile excipient for mucosal drug targeting.
Leonaviciute G; Suchaoin W; Matuszczak B; Lam HT; Mahmood A; Bernkop-Schnürch A
Carbohydr Polym; 2016 Oct; 151():743-751. PubMed ID: 27474621
[TBL] [Abstract][Full Text] [Related]
37. Chitosan-based film supported copper nanoparticles: A potential and reusable catalyst for the reduction of aromatic nitro compounds.
de Souza JF; da Silva GT; Fajardo AR
Carbohydr Polym; 2017 Apr; 161():187-196. PubMed ID: 28189228
[TBL] [Abstract][Full Text] [Related]
38. Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading.
Li P; Tan A; Prestidge CA; Nielsen HM; Müllertz A
Int J Pharm; 2014 Dec; 477(1-2):390-8. PubMed ID: 25455781
[TBL] [Abstract][Full Text] [Related]
39. Thiolated chitosans: influence of various sulfhydryl ligands on permeation-enhancing and P-gp inhibitory properties.
Sakloetsakun D; Iqbal J; Millotti G; Vetter A; Bernkop-Schnürch A
Drug Dev Ind Pharm; 2011 Jun; 37(6):648-55. PubMed ID: 21561400
[TBL] [Abstract][Full Text] [Related]
40. Systemic peptide delivery via the stomach: in vivo evaluation of an oral dosage form for salmon calcitonin.
Guggi D; Krauland AH; Bernkop-Schnürch A
J Control Release; 2003 Sep; 92(1-2):125-35. PubMed ID: 14499191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
